Clinical Pharmacology of Drugs for the Treatment of Chagas Disease-Reference-Cited by-同舟云学术

Clinical Pharmacology of Drugs for the Treatment of Chagas Disease

Published:2019 Issue: Volume: Page:299-312
ISSN:2504-3811
Container-title:Chagas Disease
language:
Short-container-title:

Author:

Garcia-Bournissen Facundo

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-030-00054-7_14

Reference83 articles.

1. Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375(9723):1388–402. PubMed PMID: 20399979.

2. Schmunis GA. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz. 2007;102(Suppl 1):75–85. PubMed PMID: 17891282.

3. Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop. 2010;115(1–2):14–21. PubMed PMID: 19932071.

4. Carlier Y. Globalization of Chagas disease (American trypanosomiasis): the situation in Europe and Belgium. Bull Mem l’Acad R Med Belg. 2011;166(10–12):347–55. discussion 56–7. PubMed PMID: 23082500.

5. Teixeira AR, Nitz N, Guimaro MC, Gomes C, Santos-Buch CA. Chagas disease. Postgrad Med J. 2006;82(974):788–98. Pubmed Central PMCID: 2653922.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance;Expert Review of Anti-infective Therapy;2024-05-31

2. Design, synthesis and biological evaluation of novel thiosemicarbazones as cruzipain inhibitors;European Journal of Medicinal Chemistry;2023-06

3. Characterization and Follow-Up of Trypanosoma cruzi Natural Populations Refractory to Etiological Chemotherapy in Oral Chagas Disease Patients;Frontiers in Cellular and Infection Microbiology;2021-04-28